Abstract
Introduction: Coronary artery disease (CAD) evaluation via coronary computed tomography angiography (CCTA) is well established, however the role of CCTA for evaluation of CAD in patients undergoing transcatheter aortic valve replacement (TAVR) for severe aortic stenosis (AS) is uncertain due to technical limitations in patient preparation (eg withholding beta-blockers, nitroglycerin and expected calcified plaque). This study evaluated the accuracy of CCTA for CAD in predominantly low-intermediate surgical risk patients (pts) undergoing evaluation for TAVR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
